Orth Peter, Reichert Paul, Wang Wenyan, Prosise Winifred W, Yarosh-Tomaine Taisa, Hammond Gerald, Ingram Richard N, Xiao Li, Mirza Urooj A, Zou Jun, Strickland Corey, Taremi S Shane, Le Hung V, Madison Vincent
Schering-Plough Research Institute, 2015 Galloping Hill Rd, Kenilworth, NJ 07033, USA.
J Mol Biol. 2004 Jan 2;335(1):129-37. doi: 10.1016/j.jmb.2003.10.037.
Adam33 is a putative asthma susceptibility gene encoding for a membrane-anchored metalloprotease belonging to the ADAM family. The ADAMs (a disintegrin and metalloprotease) are a family of glycoproteins implicated in cell-cell interactions, cell fusion, and cell signaling. We have determined the crystal structure of the Adam33 catalytic domain in complex with the inhibitor marimastat and the inhibitor-free form. The structures reveal the polypeptide fold and active site environment resembling that of other metalloproteases. The substrate-binding site contains unique features that allow the structure-based design of specific inhibitors of this enzyme.
Adam33是一种推测的哮喘易感基因,编码一种属于ADAM家族的膜锚定金属蛋白酶。ADAMs(一种去整合素和金属蛋白酶)是一族糖蛋白,与细胞间相互作用、细胞融合及细胞信号传导有关。我们已确定了Adam33催化结构域与抑制剂马立马司他复合物以及无抑制剂形式的晶体结构。这些结构揭示了与其他金属蛋白酶相似的多肽折叠和活性位点环境。底物结合位点具有独特特征,这使得基于结构设计该酶的特异性抑制剂成为可能。